Published October 2018 | Version v1
Journal article Metadata-only

Clinical significance of soluble programmed cell death ligand-1 (sPD-L1) in hepatocellular carcinoma patients treated with radiotherapy

Creators

  • 1. Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (Korea, Republic of)

Description

Purpose: To investigate the clinical implications of the soluble programmed cell death-ligand 1 (sPD-L1) level in hepatocellular carcinoma (HCC) patients treated with radiotherapy (RT).

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2017.11.027

Additional details

Identifiers

DOI
10.1016/j.radonc.2017.11.027;
PII
S0167814017327500;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
129
Journal Issue
1
Journal Page Range
p. 130-135
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
50081044
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
APOPTOSIS; HEPATOMAS; PATIENTS; RADIOTHERAPY
Descriptors DEC
CARCINOMAS; DISEASES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.